Survival outcomes and quality of life after percutaneous cryoablation for liver metastasis: A systematic review and meta-analysis

被引:3
作者
Khanmohammadi, Shaghayegh [1 ,2 ,3 ]
Behnoush, Amir Hossein [1 ,2 ,3 ]
Akhlaghpoor, Shahram [4 ]
机构
[1] Univ Tehran Med Sci, Res Ctr Immunodeficiencies, Childrens Med Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[4] Pardis Noor Med Imaging Ctr, Dept Radiol, Tehran, Iran
来源
PLOS ONE | 2023年 / 18卷 / 08期
关键词
RADIOFREQUENCY ABLATION; HEPATIC-TUMORS; THERMAL ABLATION; CHEMOTHERAPY; EXPERIENCE; HEPATECTOMY; THERMOTHERAPY; CRYOTHERAPY; CRYOSURGERY; CARCINOMA;
D O I
10.1371/journal.pone.0289975
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
BackgroundLiver metastasis is present in a wide range of malignancies, with colorectal cancer as the most common site. Several minimally invasive treatments have been suggested for managing hepatic metastases, and cryoablation is among them, yet not widely used. In this systematic review, we aimed to assess the effectiveness of percutaneous cryoablation in all types of liver metastases. MethodsA systematic search was performed in international databases, including PubMed, Scopus, Embase, and Web of Science, to find relevant studies reporting outcomes for percutaneous cryoablation in liver metastasis patients. In addition to baseline features such as mean age, gender, metastasis origin, and procedure details, procedure outcomes, including overall survival, local recurrence, quality of life (QoL), and complications, were extracted from the studies. Random-effect meta-analysis was performed to calculate the mean difference (MD) and 95% confidence interval for comparison of QoL. ResultsWe screened 2131 articles. Fifteen studies on 692 patients were included. Mean overall survival ranged from 14.5-29 months. The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure. ConclusionCryoablation is an effective procedure for the treatment of liver metastases, especially in cases that are poor candidates for liver resection. It could significantly improve QoL with favorable local recurrence.
引用
收藏
页数:17
相关论文
共 60 条
[1]   Cryoablation and immunotherapy: an overview of evidence on its synergy [J].
Aarts, B. M. ;
Klompenhouwer, E. G. ;
Rice, S. L. ;
Imani, F. ;
Baetens, T. ;
Bex, A. ;
Horenblas, S. ;
Kok, M. ;
Haanen, J. B. A. G. ;
Beets-Tan, R. G. H. ;
Gomez, F. M. .
INSIGHTS INTO IMAGING, 2019, 10 (01)
[2]   Open-configuration MR-guided microwave thermocoagulation therapy for metastatic liver tumors from breast cancer [J].
Hajime Abe ;
Yoshimasa Kurumi ;
Shigeyuki Naka ;
Hisanori Shiomi ;
Tomoko Umeda ;
Hiroyuki Naitoh ;
Yoshihiro Endo ;
Kazuyoshi Hanasawa ;
Shigehiro Morikawa ;
Tohru Tani .
Breast Cancer, 2005, 12 (1) :26-31
[3]   Repeat hepatectomy for colorectal liver metastases [J].
Adam, R ;
Bismuth, H ;
Castaing, D ;
Waechter, F ;
Navarro, F ;
Abascal, A ;
Majno, P ;
Engerran, L .
ANNALS OF SURGERY, 1997, 225 (01) :51-60
[4]   A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies [J].
Adam, R ;
Hagopian, EJ ;
Linhares, M ;
Krissat, J ;
Savier, E ;
Azoulay, D ;
Kunstlinger, F ;
Castaing, D ;
Bismuth, H .
ARCHIVES OF SURGERY, 2002, 137 (12) :1332-1339
[5]  
Adam Rene, 2009, Gastrointest Cancer Res, V3, pS15
[6]   Principles of and Advances in Percutaneous Ablation [J].
Ahmed, Muneeb ;
Brace, Christopher L. ;
Lee, Fred T., Jr. ;
Goldberg, S. Nahum .
RADIOLOGY, 2011, 258 (02) :351-369
[7]   Response to Preoperative Chemotherapy Predicts Survival in Patients Undergoing Hepatectomy for Liver Metastases from Gastric and Esophageal Cancer [J].
Andreou, Andreas ;
Vigano, Luca ;
Zimmitti, Giuseppe ;
Seehofer, Daniel ;
Dreyer, Martin ;
Pascher, Andreas ;
Bahra, Marcus ;
Schoening, Wenzel ;
Schmitz, Volker ;
Thuss-Patience, Peter C. ;
Denecke, Timm ;
Puhl, Gero ;
Vauthey, Jean-Nicolas ;
Neuhaus, Peter ;
Capussotti, Lorenzo ;
Pratschke, Johann ;
Schmidt, Sven-Christian .
JOURNAL OF GASTROINTESTINAL SURGERY, 2014, 18 (11) :1974-1986
[8]   Percutaneous Cryoablation of Metastatic Lesions from Non-Small-Cell Lung Carcinoma: Initial Survival, Local Control, and Cost Observations [J].
Bang, Hyun J. ;
Littrup, Peter J. ;
Currier, Brandt P. ;
Goodrich, Dylan J. ;
Aoun, Hussein D. ;
Klein, Lydia C. ;
Kuo, Jarret C. ;
Heilbrun, Lance K. ;
Gadgeel, Shirish ;
Goodman, Allen C. .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2012, 23 (06) :761-769
[9]   Metastasectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer [J].
Bathe, OF ;
Kaklamanos, IG ;
Moffat, FL ;
Boggs, J ;
Franceschi, D ;
Livingstone, AS .
SURGICAL ONCOLOGY-OXFORD, 1999, 8 (01) :35-42
[10]  
Carrafiello G, 2011, RADIOL MED, V116, P1059, DOI 10.1007/s11547-011-0697-2